AORT Artivion, Inc.
$22.94▼ -0.17%
Healthcare
Other
After hours
$22.94▲ +0.00%
Oct 27, 5:05 PM ET
Volume 405.2K
Avg Volume (10D) 499.5K
Key Metrics & Fundamentals
Market Cap
$1.12B
P/E Ratio
102.2
Div Yield
0.00%
52W Range
19.16 - 48.25
% vs 50 MA
-5.22%
% vs 200 MA
-22.72%
RSI-14
49.7
MACD Histogram
+0.2900
Beta (1Y vs SPY)
0.21
Free Cash Flow
-$12.01M
Gross Rev
$125.76M
Gross Profit
$80.52M
EBITDA
$2.30M
COGS
$45.24M
Operating Exp
$88.88M
Operating Income
-$8.36M
EBIT
-$8.36M
Pretax Income
-$11.70M
Net Income
-$13.51M
EPS (Diluted)
-0.28
Price & Volume History
Loading chart…
Recent News
OrthoPediatrics (KIDS) Reports Q3 Loss, Tops Revenue Estimates
Zacks · Oct 27, 2026 5:20 PM ET
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2026 Financial Results
PR Newswire · Oct 22, 2026 4:10 PM ET
Medical devices & supplies - cardiology, neurology, vascular stocks Q2 teardown: Artivion (NYSE:AORT) vs the rest
StockStory · Oct 22, 2026 11:33 AM ET
Artivion rises as Jefferies initiates at buy, sees ’attractive entry point’
Investing.com · Oct 20, 2026 11:02 AM ET
Artivion (AORT) Stock May Be 13% Undervalued On Cash Flow
Simply Wall St. · Oct 20, 2026 10:14 AM ET
Jefferies Initiates Artivion at Buy With $31 Price Target
MT Newswires · Oct 20, 2026 7:19 AM ET
1 Small-Cap Stock with Exciting Potential and 2 We Turn Down
StockStory · Oct 8, 2026 8:40 AM ET
1 Safe-and-Steady Stock with Competitive Advantages and 2 Facing Headwinds
StockStory · Oct 5, 2026 4:02 AM ET
2 Growth Stocks with All-Star Potential and 1 We Find Risky
StockStory · Sep 25, 2026 10:40 AM ET
3 Healthcare Stocks We’re Skeptical Of
StockStory · Sep 23, 2026 6:37 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See AORT's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.